Clinical trial Phase 2 Interventional Ages 18 and up

Developing a New LIFU Neuromodulation Method to Suppress Tremor

Run by University of Calgary · NCT07103265 · Data updated 2026-11-12

Not yet open. This study is not taking new participants. Its registered completion date is 2027-07-15.

The investigators aim to apply low intensity focused ultrasound neuromodulation to patients with essential tremor to evaluate the efficacy of this intervention in reducing the amplitude of hand tremor compared to sham stimulation.

Quick facts

PhasePhase 2
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment20 (estimated)
SponsorUniversity of Calgary
Academic / other
Drugs / interventionsTranscranial focused ultrasound stimulation, Sham stimulation
Trial IDNCT07103265 on ClinicalTrials.gov

What this trial studies

Transcranial ultrasound stimulation is a non-invasive brain stimulation that uses low intensity focused ultrasound (LIFU) to modulate neural activity with high spatial precision (Zadeh et al., 2024). Several human and animal studies have demonstrated that LIFU can produce lasting neuromodulatory effects, including both excitatory and inhibitory responses in the primary motor cortex (Zadeh et al., 2024). Furthermore, evidence suggests that LIFU is capable of inducing plasticity in the human brain that resembles long term potentiation or long-term depression (Zeng et al., 2024). The ability of LIFU to induce bidirectional effects, either excitatory or inhibitory, depending on sonication parameters, offers a level of flexibility in tailoring neuromodulatory interventions to individual patient needs and specific neural circuit dysfunctions. Combined with real-time neuronavigation and acoustic modeling tools, LIFU provides a promising platform for precise, personalized, and non-invasive brain stimulation. The modulatory effect of LIFU depends on sonication parameters such as frequency, attenuation, and pulse repetition frequency (Zeng et al., 2024; Manuel et al., 2020), and evidence from both preclinical and clinical studies suggests these effects can persist beyond the stimulation period consistent with long-term potentiation or long-term depression-like plasticity mechanisms (Fomenko et al., 2020; Zadeh et al., 2024). Unlike other neuromodulatory techniques such as transcranial…

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

• Diagnosis of Essential Tremor OR Diagnosis of Parkinson's Disease

Exclusion Criteria:

* Presence of any neurological diagnosis other than Essential Tremor and Parkinson's Disease
* Family history of Essential Tremor OR Parkinson's Disease
* Inability to undergo MRI or attend to the experimental study sessions

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.